DyAnsys in the News

Drug Relief wearable device

GINEBRA, 12 de junio de 2018 /PRNewswire/ -- DyAnsys Europe SARL ha anunciado que su empresa matriz, DyAnsys Inc., cuenta con la aprobación de la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA) para un dispositivo de neuroestimulación auricular que trata los síntomas del...

San Mateo, Ca -- DyAnsys Inc. announced that the U.S. Food and Drug Administration has cleared its auricular neurostimulation device, Drug Relief®, to be used as an aid to reduce the symptoms of opioid withdrawal without narcotics.


Drug Relief® is available now for providers to...

Advanced Medical Diagnostic and Monitoring Systems

Interview conducted by:
Lynn Fosse, Senior Editor, CEOCFO Magazine, Published – June 29, 2015

CEOCFO: Mr. Nageshwar, what is the concept behind DyAnsys?
Mr. Nageshwar: We established the company based on measuring medical...

San Francisco, CA – Chronic pain sufferers may find relief with a new, safe and effective non-narcotic treatment solution released by medical device maker DyAnsys, Inc. The company announced today that the four-piece system will be available in select doctors’ offices and pain management centers...

In the news

DyAnsys' Primary Relief® device provides neurostimulation therapy. The DyAnsys Primary Relief® monitor provides objective, scientific monitoring to improve P-stim therapy and enhance the opportunity for managing pain.


Email Us

Call Us